IDN 5390: an oral taxane candidate for protracted treatment schedules

The recognition of the antiangiogenic properties of taxanes provides a basis for novel therapeutic approaches. A prolonged exposure to low drug concentrations has been proposed to be the most suitable approach to exploit the antiangiogenic potential of cytotoxic agents. Such schedule is required to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pratesi, G, Laccabue, D, Lanzi, C, Cassinelli, G, Supino, R, Zucchetti, M, Frapolli, R, D'Incalci, M, Bombardelli, E, Morazzoni, P, Riva, A, Zunino, F
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2003
Gaiak:
Experimental Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2377083/
https://ncbi.nlm.nih.gov/pubmed/12644838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600784
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak